293 related articles for article (PubMed ID: 12030445)
1. A case of duodenal involvement of multiple myeloma imaged by positron emission tomography with 18F-fluorodeoxyglucose.
Yasuda S; Hoshikawa T; Yazawa N; Fukumitsu H; Ishikawa K; Suzuki T; Sadahiro S; Shimakura Y; Shibuya M; Nasu S; Tajima T; Makuuchi H
Tokai J Exp Clin Med; 2001 Dec; 26(4-6):147-51. PubMed ID: 12030445
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT Demonstrated the Multiple Myeloma From Prostate.
Cheng A; Liping F; Wang X; Zhao L; Yang J
Clin Nucl Med; 2016 Apr; 41(4):328-30. PubMed ID: 26562573
[TBL] [Abstract][Full Text] [Related]
4. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
5. Solitary extramedullary plasmacytoma of the parotid gland imaged with 18F-FDG PET/CT.
Alabed YZ; Rakheja R; Laufer J
Clin Nucl Med; 2014 Jun; 39(6):549-50. PubMed ID: 24152625
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin D-lambda type multiple myeloma presenting with FDG-PET/CT negative bone marrow involvement.
Machida H; Shinohara T; Hino H; Yoshida M; Hatakeyama N; Okano Y; Inayama M; Hosokawa E; Abe S; Naruse K; Iwahara Y; Ogushi F
Intern Med; 2011; 50(14):1483-7. PubMed ID: 21757834
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum.
Hoffmann M; Chott A; Püspök A; Jäger U; Kletter K; Raderer M
Ann Hematol; 2004 May; 83(5):276-8. PubMed ID: 15060746
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.
Albano D; Bosio G; Treglia G; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):77-84. PubMed ID: 28822997
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT Imaging of Pancreatic Plasmacytoma.
Huang WS; Zheng Y; Chen JW; Zhang GX; Xu JH
Clin Nucl Med; 2020 Jun; 45(6):489-491. PubMed ID: 32349089
[TBL] [Abstract][Full Text] [Related]
10. [18F-FDG PET-CT in a case of solitary plasmacytoma of the soft palate].
Fernández López R; Borrego Dorado I; Paz Coll A; Vázquez Albertino R; Gómez Camarero P; Sanz Viedma S
Rev Esp Med Nucl; 2010; 29(5):263-5. PubMed ID: 20663591
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of serum immunoglobulin free light chain and 18F-FDG PET/CT for therapeutic evaluation in a case with multiple plasmacytoma of bone].
Inoue T; Nagai K; Momoi A; Isahai N; Sakai T; Sekiya M
Rinsho Ketsueki; 2015 Apr; 56(4):418-22. PubMed ID: 25971273
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET in the evaluation of myeloma in 2012.
Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
[TBL] [Abstract][Full Text] [Related]
13. Whole-body (18)F-FDG PET identifies high-risk myeloma.
Durie BG; Waxman AD; D'Agnolo A; Williams CM
J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548
[TBL] [Abstract][Full Text] [Related]
14. [The value of fluorodeoxyglucose positron emission tomography in multiple myeloma].
Adam Z; Bolcák K; Stanícek J; Pour L; Hájek R; Krejcí M; Prásek J; Neubauer J; Mareschova Y; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):207-14. PubMed ID: 16722151
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
[TBL] [Abstract][Full Text] [Related]
16. Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.
Fouquet G; Guidez S; Herbaux C; Van de Wyngaert Z; Bonnet S; Beauvais D; Demarquette H; Adib S; Hivert B; Wemeau M; Berthon C; Terriou L; Coiteux V; Macro M; Decaux O; Facon T; Huglo D; Leleu X
Clin Cancer Res; 2014 Jun; 20(12):3254-60. PubMed ID: 24714772
[TBL] [Abstract][Full Text] [Related]
17. Early detection of bone marrow involvement in extramedullary plasmacytoma by whole-body F-18 FDG positron emission tomography.
Kato T; Tsukamoto E; Nishioka T; Yamazaki A; Shirato H; Kobayashi S; Asaka M; Imamura M; Tamaki N
Clin Nucl Med; 2000 Nov; 25(11):870-3. PubMed ID: 11079582
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance.
Adam Z; Bolcak K; Stanicek J; Buchler T; Pour L; Krejci M; Prasek J; Neubauer J; Vorlicek J; Hajek R
Neoplasma; 2007; 54(6):536-40. PubMed ID: 17949238
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
20. Value of FDG PET in the assessment of patients with multiple myeloma.
Bredella MA; Steinbach L; Caputo G; Segall G; Hawkins R
AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
